Cabazitaxel 99% CAS 183133-96-2 kuri Kanseri ya Prostate-Kurwanya

Ibisobanuro bigufi:

Cabazitaxel ni tagisi irwanya ibibyimba API.Igeragezwa rya Clinical ryerekanye ko rishobora kandi kugabanya ibibyimba, kugabanya imikurire cyangwa gukwirakwiza ibibyimba, kugabanya ibimenyetso bya kanseri ya prostate no kuzamura imibereho y’abarwayi.Cabazitaxel ifatanije na prednisone yo kuvura kanseri ya prostate ya hormone-yanga metastatike mbere yavuwe hamwe na dosiye irimo docetaxel.Ukuboko Bio itanga cabazitaxel 99% CAS 183133-96-2 kuri kanseri ya prostate irwanya kanseri.Kubindi bisobanuro, nyamuneka ubaze kumurongo.


Ibicuruzwa birambuye

Ibicuruzwa

Amakuru y'ibicuruzwa

Izina:Cabazitaxel

Numero ya CAS:183133-96-2

Imiti yimiti:C45H57NO14

Ibisobanuro:99%

Ibara:ifu yera cyangwa itari yera

Inkomoko:Igice cya kabiri hamwe na 10-DAB

Ubwoko:APIs

Imikorere

Igeragezwa rya Clinical ryerekanye ko cabazitaxel ishobora kugabanya ibibyimba, kugabanya imikurire cyangwa gukwirakwiza ibibyimba, no kugabanya ibimenyetso bya kanseri ya prostate.

Ahantu ho gusaba

Inganda zimiti

Imbaraga za Hande

Hande afite itsinda R&D imyaka myinshi.Iri tsinda ryasabye ibintu byinshi byavumbuwe, kandi inzira ntisanzwe kuva muri laboratoire kugeza ku bicuruzwa rusange.Uruganda rwa GMP rwiyubakiye rwatsinze isuzuma ry’amabwiriza ya Amerika FDA, EU EDQM, Ubushinwa GMP, Ubuyapani PMDA, Ositaraliya TGA, Koreya y'Epfo, Ubuhinde, Ubushinwa Tayiwani, Turukiya, Uburusiya, SGS, Dun & Bradstreet n'andi mabwiriza.Muri icyo gihe, isosiyete ifite itsinda ry’ubushakashatsi n’iterambere, kandi yagiye ikurikirana patenti nyinshi.Icyumba cyo kugerageza QC, menya neza igeragezwa ryibicuruzwa.

Uruganda

Ba umutanga mwiza wibikoresho fatizo ninganda zifite ubunyangamugayo!

Murakaza neza kundeba mwohereza imeri kurimarketing@handebio.com


  • Mbere:
  • Ibikurikira: